,i #aaeth ,,congress #ast ,session ,h4 ,r4 #aehg ,,in ,,the ,,house ,,of ,,representatives ,march #af1 #bjag,ms4 ,slaughter 7for herself1 ,ms4 ,de,lauro1 ,mr4 ,cicilline1 ,mr4 ,connolly1 ,mr4 ,de,fazio1 ,mr4 ,deutch1 ,mr4 ,langevin1 ,mr4 ,ted ,lieu of ,california1 ,mr4 ,lowenthal1 ,ms4 ,mc,collum1 ,mr4 ,moulton1 ,mrs4 ,napolitano1 ,ms4 ,norton1 ,ms4 ,speier1 ,ms4 ,tsongas1 ,mr4 ,yarmuth1 ,mr4 ,jeffries1 and ,ms4 ,shea-,porter7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend the ,federal ,food1 ,drug1 and ,cosmetic ,act to preserve the effectiveness of medically important antimicrobials used in the treatment of human and animal diseases4 #a4 ,short title ,this ,act may be cited as the ,preservation of ,antibiotics for ,medical ,treatment ,act of #bjag4 #b4 ,findings ,the ,congress finds the following3 7#a7 ,all uses of antibiotics1 including for food-producing animals1 have the potential to cause resistance and contribute to the development of antibiotic-resistant bacterial infections in people4 7#b7 ,in #aigg1 the ,food and ,drug ,administration 7,,fda7 concluded that feeding livestock low doses of antibiotics used in human disease treatment could promote the development of antibiotic resistance in bacteria4 ,however1 the ,food and ,drug ,administration did not act in response to these findings1 despite laws requiring the agency to do so4 7#c7 ,in #bjab1 the ,food and ,drug ,administration ,guidance for ,industry #bji provided a summary of over #dj years of peer-reviewed scientific literature regarding use of antimicrobial drugs in livestock which reiterated that the use of antibiotics in animals contributes to the resistance in human pathogens and concludes that strategies for controlling antibiotic resistance1 including limiting medically important antimicrobial drugs in food-producing animals only to uses that are considered necessary for assuring animal health are needed4 7#d7 ,the #bjad ,president's ,council of ,advisors on ,science and ,technology ,report to the ,president on ,combating ,antibiotic-,resistant ,bacteria also concludes that substantial evidence exists that the use of antibiotics in food animals promotes the development and spread of antibiotic resistance in bacteria that can spread to people and that it is clear that agricultural use of antibiotics can affect human health4 7#e7 ,recently published scientific studies have shown that food-producing animals1 and animal production facilities1 are a source of antibiotic-resistant bacteria which have infected humans and present an increased risk of acquiring and antibiotics resistant infection4 7#f7 ,antibiotic resistance is a crisis which threatens public health1 the economy1 and national security4 7#g7 ,in #bjac1 the ,centers for ,disease ,control and ,prevention estimated that antibiotic-resistant infections cause at least #b million infections1 #bc1jjj deaths1 #h million additional hospital days1 and #bj to #ce billion in excess direct health care costs each year in the ,united ,states4 7#h7 ,the #bjad ,world ,health ,organization report1 ,antimicrobial ,resistance3 ,global ,report on ,surveillance #bjad1 concluded that antimicrobial resistance is a current reality and the problem is so serious that it threatens the achievements of modern medicine4 7#i7 ,without effective antibiotics-- 7,a7 common infections could become untreatable--even fatal2 and 7,b7 medical advances such as joint replacements1 ,cesarean sections1 organ transplants and chemotherapy could become nonviable4 7#aj7 ,antibiotic resistance1 resulting in a reduced number of effective antibiotics1 may significantly impair the ability of the ,united ,states to respond to terrorist attacks involving bacterial infections1 such as anthrax and smallpox1 or to an event resulting in a large influx of hospitalized patients4 7#aa7 ,in #bjaa1 the ,food and ,drug ,administration determined that-- 7,a7 #ac4e million kilograms of antibacterial drugs were sold for use on food animals in the ,united ,states in #bjaj2 7,b7 #c4c million kilograms of antibacterial drugs were used for human health in #bjaj2 and 7,c7 therefore1 #hj percent of antibacterial drugs disseminated in the ,united ,states in #bjaj were sold for use on food animals1 rather than being used for human health4 7#ab7 ,the ,,fda ,annual ,summary ,report on ,antimicrobials ,sold or ,distributed in #bjab for ,use in ,food-,producing ,animals showed that the use of medically important antibiotics in food-producing animals increased #af percent from #bjji to #bjab4 7#ac7 7,a7 ,in #bjjc1 the ,food and ,drug ,administration modified the drug approval process for antibiotics to recognize the development of resistant bacteria as an important aspect of safety1 but most antibiotics currently used in animal production systems for nontherapeutic purposes were approved before the ,food and ,drug ,administration began considering resistance during the drug-approval process4 7,b7 ,the ,food and ,drug ,administration has not established a schedule for reviewing those existing approvals4 7#ad7 ,a stated goal of ,,fda ,guidance documents #bji and #bac is a reduction in the overall consumption of antibiotics4 ,the ,,fda policy continues to allow the use of antibiotics for routine disease prevention without requiring evidence of the presence of a specific disease or requiring the mitigation of conditions which elevate disease risk4 7#ae7 ,there is inadequate distinction between usage for disease prevention and production purposes1 such as growth promotion1 on ,,fda approved drug labels4 ,a #bjad analysis of the approved animal drugs affected by ,guidance #bac by the ,pew ,charitable ,trusts found that numerous approved drug labels contained overlapping indications for growth-promotion and disease prevention4 7#af7 ,the ,european ,union 7,,eu7 banned the use of antibiotics for growth promotion in #bjjf1 a full decade before the ,,fda's voluntary approach will go into effect4 7#ag7 ,since the ,,eu ban1 antibiotic usage has decreased without affecting livestock production4 7#ah7 ,in #bjaj1 the ,danish ,veterinary and ,food ,administration testified that the ,danish ban of the nontherapeutic use of antibiotics in food-animal production resulted in a marked reduction in antimicrobial resistance in multiple bacterial species1 including ,campylobacter and ,enterococci4 7#ai7 ,the experience in the ,netherlands has shown that during the phaseout use indications for growth promotion were completely supplanted by disease prevention4 ,total antibiotic consumption remained constant4 ,after the implementation of mandatory reduction targets and improved surveillance of usage practices antibiotic consumption declined ahead of target without impacting production levels4 7#bj7 ,in #bjji1 the ,congressional ,research ,service concluded that without restrictions on the use of antimicrobial drugs in the production of livestock1 export markets for livestock and poultry could be negatively impacted due to restrictions on the use of antibiotics in other nations4 7#ba7 ,the ,american ,medical ,association1 the ,infectious ,disease ,society of ,america1 the ,american ,public ,health ,association1 the ,national ,association of ,county and ,city ,health ,officials1 and the ,national ,sustainable ,agriculture ,coalition are among the over #djj organizations representing health1 consumer1 agricultural1 environmental1 humane1 and other interests that have supported enactment of legislation to phaseout nontherapeutic use in farm animals of medically important antimicrobials4 #c4 ,purpose ,the purpose of this ,act is to preserve the effectiveness of medically important antimicrobials used in the treatment of human and animal diseases4 #d4 ,proof of safety of medically important antimicrobials 7a7 ,applications pending or submitted after enactment ,section #eab7;d77#a7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;b7d77#a77 is amended-- 7#a7 in the first sentence-- 7,a7 in subparagraph 7,h71 by striking or at the end2 7,b7 in subparagraph 7,i71 by inserting or at the end2 and 7,c7 by inserting after subparagraph 7,i7 the following3 7,j7 with respect to a medically important antimicrobial 7as defined in subsection 7q771 the applicant has failed to demonstrate that there is a reasonable certainty of no harm to human health due to the development of antimicrobial resistance that is attributable1 in whole or in part1 to the nontherapeutic use 7as defined in subsection 7q77 of the medically important antimicrobial or drug2 2 and 7#b7 in the second sentence1 by striking 7,a7 through 7,i7 and inserting 7,a7 through 7,j74 7b7 ,phased elimination of nontherapeutic use in animals of medically important antimicrobials ,section #eab of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cfj;b7 is amended by adding at the end the following3 7q7 ,phased elimination of nontherapeutic use in animals of medically important antimicrobials 7#a7 ,applicability ,this paragraph applies to the nontherapeutic use in a food-producing animal of a drug-- 7,a7 that is a medically important antimicrobial2 or 7,b7 7i7 for which there is in effect an approval of an application or an exemption under subsection 7b71 7i71 or 7j7 of section #eje2 or 7ii7 that is otherwise marketed for human use4 7#b7 ,withdrawal ,the ,secretary shall withdraw the approval of a nontherapeutic use in food-producing animals of a drug described in paragraph 7#a7 on the date that is #b years after the date of enactment of this subsection unless-- 7,a7 before the date that is #b years after the date of the enactment of this subsection1 the ,secretary makes a final written determination that the holder of the approved application has demonstrated that there is a reasonable certainty of no harm to human health due to the development of antimicrobial resistance that is attributable in whole or in part to the nontherapeutic use of the drug2 or 7,b7 before the date specified in subparagraph 7,a71 the ,secretary makes a final written determination under this subsection1 with respect to a risk analysis of the drug conducted by the ,secretary and other relevant information1 that there is a reasonable certainty of no harm to human health due to the development of antimicrobial resistance that is attributable in whole or in part to the nontherapeutic use of the drug4 7#c7 ,exemptions ,except as provided in paragraph 7#e71 if the ,secretary grants an exemption under section #eje7;i7 for a drug that is a medically important antimicrobial1 the ,secretary shall rescind each approval of a nontherapeutic use in a food-producing animal of the medically important antimicrobial as of the date that is #b years after the date on which the ,secretary grants the exemption4 7#d7 ,approvals ,except as provided in paragraph 7#e71 if an application for a drug that is a medically important antimicrobial is submitted to the ,secretary under section #eje7;b71 the ,secretary shall rescind each approval of a nontherapeutic use in a food-producing animal of the medically important antimicrobial as of the date that is #b years after the date on which the application is submitted to the ,secretary4 7#e7 ,exceptions ,paragraph 7#c7 or 7#d71 as the case may be1 shall not apply if-- 7,a7 before the date on which approval would be rescinded under that paragraph1 the ,secretary makes a final written determination that the holder of the application for the approved nontherapeutic use has demonstrated that there is a reasonable certainty of no harm to human health due to the development of antimicrobial resistance that is attributable in whole or in part to the nontherapeutic use in the food-producing animal of the medically important antimicrobial2 or 7,b7 before the date specified in subparagraph 7,a71 the ,secretary makes a final written determination1 with respect to a risk analysis of the medically important antimicrobial conducted by the ,secretary and any other relevant information1 that there is a reasonable certainty of no harm to human health due to the development of antimicrobial resistance that is attributable in whole or in part to the nontherapeutic use of the medically important antimicrobial4 7#f7 ,definition ,in this subsection3 7,a7 ,the term medically important antimicrobial means a drug that-- 7i7 is intended for use in food-producing animals2 and 7ii7 is composed wholly or partly of-- 7,i7 any kind of penicillin1 tetracycline1 macrolide1 lincosamide1 streptogramin1 aminoglycoside1 sulfonamide1 or cephalosporin2 or 7,,ii7 a drug from an antimicrobial class that is listed as highly important1 critically important1 or important by the ,world ,health ,organization in the latest edition of its publication entitled ,critically ,important ,antimicrobials for ,human ,medicine 7or a successor publication74 7,b7 ,the term therapeutic use1 with respect to a medically important antimicrobial1 means the use of antimicrobials for the specific purpose of treating an animal with a documented disease or infection4 ,such term does not include the continued use of such an antimicrobial in the animal after the disease or infection is resolved4 7,c7 ,the term nontherapeutic use-- 7i7 means administration of antibiotics to an animal through feed and water 7or1 in poultry hatcheries1 through any means7 for purposes 7such as growth promotion1 feed efficiency1 weight gain1 or disease prevention7 other than therapeutic use or nonroutine disease control2 and 7ii7 includes any repeated or regular pattern of use of medically important antimicrobials for purposes other than therapeutic use or nonroutine disease control4 7,d7 ,the term noncustomary situation does not include normal or standard practice and conditions on the premises that facilitate the transmission of disease4 7,e7 ,the term nonroutine disease control means the use of antibiotics on an animal that is not sick but where it can be shown that a particular disease or infection is present1 or is likely to occur because of a specific1 noncustomary situation1 on the premises at the barn1 house1 pen1 or other level at which the animal is kept4 4 #e4 ,limitations on use of medically important antimicrobials for nonroutine disease control 7a7 ,prohibited acts ,section #cja of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cca7 is amended by adding at the end the following3 7ccc7 ,the administration of a medically important antimicrobial to a food-producing animal for nonroutine disease control in violation of the requirements of section #eab;,a4 4 7b7 ,requirements ,chapter ,v of the ,federal ,food1 ,drug1 and ,cosmetic ,act is amended by inserting after section #eab of such ,act 7#ba ,u4,s4,c4 #cfj;b7 the following3 #eab;,a4 ,limitations on use of medically important antimicrobials for nonroutine disease control 7a7 ,prohibition ,it shall be unlawful to administer 7including by means of animal feed7 a medically important antimicrobial to a food-producing animal for nonroutine disease control unless-- 7#a7 there is a significant risk that a disease or infection present on the premises will be transmitted to the food-producing animal2 7#b7 the administration of the medically important antimicrobial to the food-producing animal is necessary to prevent or reduce the risk of transmission of the disease or infection described in paragraph 7#a72 7#c7 the medically important antimicrobial is administered to the food-producing animal for nonroutine disease control for the shortest duration possible to prevent or reduce the risk of transmission of the disease or infection described in paragraph 7#a7 to the animal2 and 7#d7 the medically important antimicrobial is administered-- 7,a7 at a scale no greater than the barn1 house1 or pen level2 and 7,b7 to the fewest animals possible to prevent or reduce the risk of transmission of the disease or infection described in paragraph 7#a74 7b7 ,definitions ,in this section3 7#a7 ,the term food-producing animal means a food-producing animal intended for sale in interstate commerce4 7#b7 ,the terms medically important antimicrobial and nonroutine disease control have the meanings given to such terms in section #eab7q74 4 7c7 ,applicability ,the amendments made by this section apply beginning on the date that is #f months after the date of the enactment of this ,act4